Literature DB >> 4932139

Xerostomia in Sjögren's syndrome. Evaluation by sequential salivary scintigraphy.

G L Schall, L G Anderson, R O Wolf, J R Herdt, T M Tarpley, N A Cummings, L S Zeiger, N Talal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4932139

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  43 in total

1.  Medical Staff Conference: Recent clinical and experimental developments in Sjögren's syndrome.

Authors: 
Journal:  West J Med       Date:  1975-01

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren's syndrome.

Authors:  Tamer Aksoy; Pinar Ozgen Kiratli; Belkis Erbas
Journal:  Clin Rheumatol       Date:  2012-06-26       Impact factor: 2.980

4.  The uses and limitations of radioisotopes in the investigation of gastrointestinal diseases.

Authors:  P Braunstein; C S Song
Journal:  Am J Dig Dis       Date:  1975-01

Review 5.  Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.

Authors:  Ibtisam Al-Hashimi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjögren's syndrome.

Authors:  R La Corte; G Bajocchi; A Potena; M Govoni; F Trotta
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

7.  Sjoegren's syndrome: MR imaging of the parotid gland.

Authors:  T J Vogl; S H Dresel; G Grevers; M Späth; C Bergman; J Balzer; J Lissner
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

8.  Primary Sjögren's syndrome treated with Efamol/Efavit. A double-blind cross-over investigation.

Authors:  R Manthorpe; S Hagen Petersen; J U Prause
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

9.  T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome.

Authors:  N Talal; R A Sylvester; T E Daniels; J S Greenspan; R C Williams
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  Antibodies to cellular antigens in Sjögren's syndrome.

Authors:  M A Alspaugh; E M Tan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.